bromocriptine has been researched along with risperidone in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 10 (66.67) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Druck, T; Hamblin, MW; Huebner, K; Khan, N; Kohen, R; Lachowicz, JE; Meltzer, HY; Metcalf, MA; Roth, BL; Sibley, DR | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Tollin, SR | 1 |
Odawara, T | 1 |
Ananth, J; Burgoyne, K; Gunatilake, S; Parameswaran, S; Sidhom, T | 1 |
Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F | 1 |
Baran, AS; Rack, MJ; Richert, AC; Roffwarg, HP | 1 |
Akan, M; Akdede, B; Akvardar, Y; Kosehasanogullari, SG; Tunca, Z | 1 |
Feng, XJ; Liu, RM; Sze, CW; Tan, QR; Tong, Y; Wang, CY; Yuan, HN; Zhang, JZ; Zhang, YB; Zhang, ZJ | 1 |
Lee, J; Ng, KW; Swapna, V | 1 |
Ahmed, RH; Bondi, CO; Kline, AE; Olugbade, YT; Phelps, TI | 1 |
2 review(s) available for bromocriptine and risperidone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Organic catatonic disorder].
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Bromocriptine; Catatonia; Dopamine Agonists; Dopamine Antagonists; Electroconvulsive Therapy; Female; Humans; Meningoencephalitis; Psychotic Disorders; Risperidone | 2003 |
1 trial(s) available for bromocriptine and risperidone
Article | Year |
---|---|
A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Topics: Adult; Amenorrhea; Antipsychotic Agents; Bromocriptine; Drug Therapy, Combination; Drugs, Chinese Herbal; Estradiol; Female; Glycyrrhiza; Humans; Hyperprolactinemia; Oligomenorrhea; Paeonia; Phytotherapy; Plant Extracts; Progesterone; Prolactin; Risperidone; Schizophrenia; Testosterone | 2008 |
12 other study(ies) available for bromocriptine and risperidone
Article | Year |
---|---|
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line, Transformed; Chlorocebus aethiops; Chromosome Mapping; Chromosomes, Human, Pair 1; Cloning, Molecular; Clozapine; DNA, Complementary; Genes; Humans; Kinetics; Molecular Sequence Data; Open Reading Frames; Protein Conformation; Rats; Receptors, Serotonin; Recombinant Proteins; Sequence Alignment; Sequence Homology, Nucleic Acid; Serotonin Agents; Signal Transduction; Species Specificity | 1996 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Hypogonadism; Male; Middle Aged; Prolactin; Psychotic Disorders; Risperidone | 2000 |
Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Clozapine; Dantrolene; Dibenzothiazepines; Dopamine Agonists; Female; Humans; Intubation; Male; MEDLINE; Mental Disorders; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Respiration, Artificial; Risperidone; Treatment Outcome | 2004 |
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cataract Extraction; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Remission Induction; Risperidone; Visual Perception | 2004 |
Cardiopulmonary complications of ergot-derivative dopamine agonists.
Topics: Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia; Pergolide; Pulmonary Fibrosis; Risperidone | 2004 |
Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
Topics: Anemia, Hypochromic; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; beta-Thalassemia; Bipolar Disorder; Bromocriptine; Drug Therapy, Combination; Female; Glasgow Coma Scale; Humans; Hypothyroidism; Lithium Compounds; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia; Risperidone; Venous Thrombosis | 2007 |
Management of a patient with schizophrenia and underlying pituitary macroadenoma.
Topics: Adenoma; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bromocriptine; Dopamine Antagonists; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Pituitary Neoplasms; Quinolones; Risperidone; Schizophrenia; Serotonin Antagonists; Trifluoperazine | 2010 |
Divergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficits.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain Injuries; Bromocriptine; Cognition Disorders; Dopamine Agonists; Haloperidol; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function; Risperidone; Time Factors | 2015 |